Chemoinformaics analysis of 1,11-TRIDECADIENE
| Molecular Weight | 180.335 | nRot | 9 |
| Heavy Atom Molecular Weight | 156.143 | nRig | 2 |
| Exact Molecular Weight | 180.188 | nRing | 0 |
| Solubility: LogS | -5.839 | nHRing | 0 |
| Solubility: LogP | 6.184 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 37.713 |
| nHD | 0 | BPOL | 24.077 |
| QED | 0.351 |
| Synth | 2.313 |
| Natural Product Likeliness | 1.388 |
| NR-PPAR-gamma | 0.05 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.539 |
| MDCK | 0.0000155 |
| BBB | 0.727 |
| PPB | 0.982176 |
| VDSS | 1.859 |
| FU | 0.0288882 |
| CYP1A2-inh | 0.953 |
| CYP1A2-sub | 0.206 |
| CYP2c19-inh | 0.665 |
| CYP2c19-sub | 0.144 |
| CYP2c9-inh | 0.426 |
| CYP2c9-sub | 0.927 |
| CYP2d6-inh | 0.278 |
| CYP2d6-sub | 0.72 |
| CYP3a4-inh | 0.623 |
| CYP3a4-sub | 0.102 |
| CL | 6.479 |
| T12 | 0.183 |
| hERG | 0.011 |
| Ames | 0.025 |
| ROA | 0.022 |
| SkinSen | 0.957 |
| Carcinogencity | 0.096 |
| EI | 0.988 |
| Respiratory | 0.274 |
| NR-Aromatase | 0.021 |
| Antiviral | No |
| Prediction | 0.564829 |